Clinical Trial

Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 3, 2026 (before its estimated July 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study will be conducted retrospectively and prospectively, using bone marrow (BM) or peripheral blood (PB) samples or biopsies of lymph nodes or tissues with metastatic involvement taken from previously stored samples here at the University Hospital of Parma or taken from patients that need to underwent diagnostic evaluation for a suspect or a defined diagnosis of hematological malignancies collected at the University Hospital of Parma.
Trial Details
NCT Number NCT07445984
Lead Sponsor Azienda Ospedaliero-Universitaria di Parma
Conditions Chronic Leukemia, Acute Leukemia, Myeloproliferative Disorders, Lymphoproliferative Disorders, Myelodysplastic Disorders
Enrollment 250 participants
Start Date 2021-07-28
Primary Completion 2026-07-28 (estimated)
Study Completion 2026-07-28 (estimated)
Updated on ClinicalTrials.gov 2026-03-03